Nerandomilast (Jascayd) approved to treat adult patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (8 July 2026) approved the medicine nerandomilast (Jascayd) to treat adults…